Abstract
Superior cervical ganglia 10 (SCG10), as a microtubule (MT) destabilizer, maintains MT homeostasis and has a critical role in neuronal development, but its function in tumorigenesis has not been characterized. In the present study, we demonstrated that p21-activated kinase 4 (PAK4)-mediated SCG10 phosphorylation regulates MT homeostasis in metastatic gastric cancer. Our results indicate that SCG10 is a physiological substrate of PAK4, which is phosphorylated on serine 50 (Ser50) in a PAK4-dependent manner. Phosphorylated SCG10 regulated MT dynamics to promote gastric cancer cell migration and invasion in vitro and metastasis in a xenograft mouse models. Inhibiting PAK4, either by LCH-7749944 or RNA interference, resulted in the inhibition of Ser50 phosphorylation and a blockade to cell invasion, suggesting that PAK4-SCG10 signaling occurs in gastric cancer cell invasion. Moreover, we demonstrated a strong positive correlation between PAK4 and phospho-Ser50 SCG10 expression in gastric cancer samples. We also showed that high expression of SCG10 phospho-Ser50 is highly correlated to an aggressive phenotype of clinical gastric cancer. These findings revealed a novel function of SCG10 in promoting invasive potential of gastric cancer cells, suggesting that blocking PAK4-mediated SCG10 phosphorylation might be a potential therapeutic strategy for metastasis of gastric cancer.
Similar content being viewed by others
References
Steeg PS . Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003; 3: 55–63.
Kumar R, Gururaj AE, Barnes CJ . p21-activated kinases in cancer. Nat Rev Cancer 2006; 6: 459–471.
Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V et al. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 1998; 17: 6527–6540.
Li X, Minden A . PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem 2005; 280: 41192–41200.
Wells CM, Whale AD, Parsons M, Masters JR, Jones GE . PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci 2010; 123: 1663–1673.
Qu J, Cammarano MS, Shi Q, Ha KC, de Lanerolle P, Minden A . Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol 2001; 21: 3523–3533.
Zhang H, Li Z, Viklund EK, Stromblad S . P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration. J Cell Biol 2002; 158: 1287–1297.
Li X, Ke Q, Li Y, Liu F, Zhu G, Li F . DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1. Int J Biochem Cell Biol 2010; 42: 70–79.
Whale AD, Dart A, Holt M, Jones GE, Wells CM . PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity. Oncogene 2013; 32: 2114–2120.
Paliouras GN, Naujokas MA, Park M . Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor. Mol Cell Biol 2009; 29: 3018–3032.
Liu Y, Chen N, Cui X, Zheng X, Deng L, Price S et al. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene 2010; 29: 5883–5894.
Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR et al. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 2002; 277: 550–558.
Kim JH, Kim HN, Lee KT, Lee JK, Choi SH, Paik SW et al. Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol 2008; 29: 41–49.
Siu MK, Chan HY, Kong DS, Wong ES, Wong OG, Ngan HY et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci USA 2010; 107: 18622–18627.
Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X, Lee HJ et al. The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res 2008; 6: 1215–1224.
Begum A, Imoto I, Kozaki K, Tsuda H, Suzuki E, Amagasa T et al. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Sci 2009; 100: 1908–1916.
Tararuk T, Ostman N, Li W, Bjorkblom B, Padzik A, Zdrojewska J et al. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 2006; 173: 265–277.
Charbaut E, Curmi PA, Ozon S, Lachkar S, Redeker V, Sobel A . Stathmin family proteins display specific molecular and tubulin binding properties. J Biol Chem 2001; 276: 16146–16154.
Mori N, Morii H . SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 2002; 70: 264–273.
Grenningloh G, Soehrman S, Bondallaz P, Ruchti E, Cadas H . Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J Neurobiol 2004; 58: 60–69.
Westerlund N, Zdrojewska J, Padzik A, Komulainen E, Bjorkblom B, Rannikko E et al. Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate. Nat Neurosci 2011; 14: 305–313.
Paradis V, Dargere D, Bieche Y, Asselah T, Marcellin P, Vidaud M et al. SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules. Am J Pathol 2010; 177: 1791–1797.
Togano T, Kurachi M, Watanabe M, Grenningloh G, Igarashi M . Role of Ser50 phosphorylation in SCG10 regulation of microtubule depolymerization. J Neurosci Res 2005; 80: 475–480.
Stein R, Mori N, Matthews K, Lo LC, Anderson DJ . The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons. Neuron 1988; 1: 463–476.
Bieche I, Maucuer A, Laurendeau I, Lachkar S, Spano AJ, Frankfurter A et al. Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP. Genomics 2003; 81: 400–410.
Wells CM, Abo A, Ridley AJ . PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J Cell Sci 2002; 115: 3947–3956.
Ahmed T, Shea K, Masters JR, Jones GE, Wells CM . A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cell Signal 2008; 20: 1320–1328.
Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K et al. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 2008; 19: 2003–2013.
Ahn HK, Jang J, Lee J, Se Hoon P, Park JO, Park YS et al. P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Transl Oncol 2011; 4: 345–349.
Callow MG, Zozulya S, Gishizky ML, Jallal B, Smeal T . PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci 2005; 118: 1861–1872.
Mak GW, Chan MM, Leong VY, Lee JM, Yau TO, Ng IO et al. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Cancer Res 2011; 71: 2949–2958.
Zhang HJ, Siu MK, Yeung MC, Jiang LL, Mak VC, Ngan HY et al. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis 2011; 32: 765–771.
Schaefer AW, Kabir N, Forscher P . Filopodia and actin arcs guide the assembly and transport of two populations of microtubules with unique dynamic parameters in neuronal growth cones. J Cell Biol 2002; 158: 139–152.
Palazzo AF, Gundersen GG . Microtubule-actin cross-talk at focal adhesions. Sci STKE 2002; 2002: pe31.
Jeon TY, Han ME, Lee YW, Lee YS, Kim GH, Song GA et al. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. Br J Cancer 2010; 102: 710–718.
Ghosh R, Gu R, Tillman E, Yuan J, Wang Y, Fazli L et al. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. Prostate 2007; 67: 1038–1052.
Takahashi M, Yang XJ, Lavery TT, Furge KA, Williams BO, Tretiakova M et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 2002; 62: 6598–6605.
Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003; 2: 107–116.
Li N, Jiang P, Du W, Wu Z, Li C, Qiao M et al. Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules. Proc Natl Acad Sci USA 2011; 108: 12851–12856.
Zhang J, Wang J, Guo Q, Wang Y, Zhou Y, Peng H et al. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. Cancer Lett 2012; 317: 24–32.
Li Y, Shao Y, Tong Y, Shen T, Zhang J, Li Y et al. Nucleo-cytoplasmic shuttling of PAK4 modulates beta-catenin intracellular translocation and signaling. Biochim Biophys Acta 2012; 1823: 465–475.
McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986; 46 (8 Suppl): 4244s–4248s.
Acknowledgements
We thank Yongxi Song, Jianhua Wu and Feng Zhao for their technical assistance with the animal experiments. We are grateful to Gary M Bokoch, Audrey Minden and Bruce Mayer for providing essential expression vectors. This work was supported by grants from the National Natural Science Foundation of China (Nos 90813038, 31171360, 81230077 and 81130042) and Doctoral fund of Ministry of Education of China (No. 20102104110016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Guo, Q., Su, N., Zhang, J. et al. PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis. Oncogene 33, 3277–3287 (2014). https://doi.org/10.1038/onc.2013.296
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.296
- Springer Nature Limited
Keywords
This article is cited by
-
Proximity proteomics identifies PAK4 as a component of Afadin–Nectin junctions
Nature Communications (2021)
-
A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells
Oncogene (2019)
-
Inhibitors of the p21 Activated Kinases
Current Pharmacology Reports (2018)
-
PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth
Cell Death & Disease (2017)
-
PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration
Scientific Reports (2017)